Addiction, SubstanceAlcohol Use DisorderAlcohol DependenceAlcohol Withdrawal
Investigational drug(s) / intervention(s)
French version PAWSS
French version PAWSS: French version of the Prediction of Alcohol Withdrawal Severity Scale
Study summary
The goal of this observational study is to validate the French version of the PAWSS scale in a population of patients with Alcohol Use Disorders. Prediction of Alcohol Withdrawal Severity Scale (PAWSS) has an excellent psychometric characteristics and predictive value of complicated alcohol withdrawal.
The main question it aims to answer is:
Are the psychometric properties of the French version of the PAWSS scale comparable to those of the English version in a population of alcohol use disorders subjects?
AUDs participants are included and followed for three days during their hospitalization, They will performed several scales and surveys (DSM-5 AUD criteria, AUDIT, French version of PAWSS and CIWA-AR).
Eligibility
Sex
ALL
Min age
18 Years
Max age
60 Years
Healthy volunteers
No
Inclusion Criteria:
* Male or female, aged 18 to 60 years
* Subjects with DSM-5 criteria for alcohol use disorders (AUD)
* Subjects hospitalized for scheduled withdrawal or patients developing alcohol withdrawal hospitalized for another reason.
* Subjects who understand French
* Subject affiliated to the French social security system
* Subject having given their written consent to the study
Exclusion Criteria:
* Subjects transferred from other hospitalization services for whom a withdrawal syndrome could have already been treated.
* Subjects scheduled for discharge within 48 hours.
* Subjects with known uncontrolled epilepsy.
* Subjects unable to understand the questionnaire.
* Subjects unable to give consent or not volunteering for the study.
* Subjects under guardianship or curatorship.
Primary outcome measure(s)
Psychometric qualities evaluation of French PAWSS — 3 days The primary endpoint is the evaluation of the psychometric qualities of the French version of PAWSS scale (PRSAC) by measuring predictive performance through the calculation of sensitivity, specificity, and positive and negative predictive values.
Trial sites (1)
Facility
City
Region
Status
Etablissement Public de Santé Barthélemy Durand
Étampes
France
Recruiting
More Etablissement Public de Santé Barthélemy Durand trials in France
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
We use cookies to analyse site traffic and improve your experience. With your consent, we may also use cookies for advertising. You can change your choice at any time.